OMD has won the global business for the animal health division of Boehringer Ingelheim. The billings are estimated to be between USD$90 million to USD$100 million and Zenith is believed to be the incumbent.
The assignment covers Asia-Pacific, Europe, Middle East and Africa and the US – the largest market for BI accounting for 60% of billings. The remit includes cross media and channel planning and buying.
OMD’s mandate covers petcare products Frontline and NexGard.
source: http://www.mumbrella.asia
MARKETING Magazine is not responsible for the content of external sites.
An afternoon of conversations we never had, with leaders most of you never met.
Discover what’s possible from those who made it possible. Plus a preview of The HAM Agency Rankings REPORT 2024.
Limited seats: [email protected]
BOOK SEATS NOW